Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dysphagia
ADR ID BADD_A01371
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.06      Gastrointestinal signs and symptoms NEC
07.01.06.003      Dysphagia
Description A disorder characterized by difficulty in swallowing. [CTCAE] Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS. [MeSH]
MedDRA Code 10013950
MeSH ID D003680
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Deglutition disorder | Disorder deglutition | Dysphagia | Swallowing difficult | Swallowing disorder | Swallowing impaired | Swallowing spasm | Dysphagia aggravated | Aphagia | Oropharyngeal dysphagia | Esophageal dysphagia | Oesophageal dysphagia | Unable to swallow | Pharyngoesophageal dysphagia | Pharyngo-oesophageal dysphagia | Deglutition Disorders | Deglutition Disorder | Disorders, Deglutition | Swallowing Disorders | Swallowing Disorder | Oropharyngeal Dysphagia | Dysphagia, Oropharyngeal | Esophageal Dysphagia | Dysphagia, Esophageal
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02526Larotrectinib0.000246%
BADD_D02528Asciminib0.000437%
BADD_D02531Avapritinib0.000492%
BADD_D02539Calcium0.000587%
BADD_D02540Capmatinib0.004679%
BADD_D02542Cenobamate0.000523%
BADD_D02546Daprodustat0.000435%
BADD_D02548Darolutamide0.003337%
BADD_D02552Encorafenib0.003727%
BADD_D02553Entrectinib0.000739%
BADD_D02554Fedratinib0.000381%
BADD_D02556Ferrous cation0.001255%
BADD_D02558Gadolinium cation (3+)-
BADD_D02559Glasdegib0.000246%
BADD_D02561Isavuconazole0.004113%
BADD_D02573Mobocertinib0.000168%
BADD_D02574Molnupiravir0.009823%
BADD_D02576Opicapone0.001541%
BADD_D02577Oseltamivir acid0.004115%
BADD_D02582Pemigatinib0.000246%
BADD_D02585Pralsetinib0.000627%
BADD_D02591Ripretinib0.001254%
BADD_D02592Risdiplam0.011251%
BADD_D02593Selpercatinib0.000873%
BADD_D02596Sotorasib0.000548%
BADD_D02603Tucatinib0.001119%
BADD_D02609Zanubrutinib0.000761%
BADD_D02635Rupatadine--
The 21th Page    First    Pre   21    Total 21 Pages